Cargando…

Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging

BACKGROUND: Significant numbers of prostate cancer (PCa) patients experience tumour upstaging and upgrading in surgical specimens that cause serious problems in timely and proper selection of the treatment strategy. This study was aimed at the evaluation of a set of established epigenetic biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakavicius, Arnas, Daniunaite, Kristina, Zukauskaite, Kristina, Barisiene, Marija, Jarmalaite, Sonata, Jankevicius, Feliksas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683454/ https://www.ncbi.nlm.nih.gov/pubmed/31383039 http://dx.doi.org/10.1186/s13148-019-0716-z

Ejemplares similares

The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival
por: Bakavičius, Arnas, et al.
Publicado: (2020)

Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence
por: Daniunaite, Kristina, et al.
Publicado: (2021)

The utility of urine-circulating miRNAs for detection of prostate cancer
por: Stuopelyte, Kristina, et al.
Publicado: (2016)

Decreased expression of MT1E is a potential biomarker of prostate cancer progression
por: Demidenko, Rita, et al.
Publicado: (2017)

Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma
por: Kubiliute, Raimonda, et al.
Publicado: (2021)

Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer Patients
por: Januskevicius, Tomas, et al.
Publicado: (2023)

Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
por: Barisiene, Marija, et al.
Publicado: (2020)

Frequent down-regulation of ABC transporter genes in prostate cancer
por: Demidenko, Rita, et al.
Publicado: (2015)

Malignant mixed epithelial and stromal tumour of the kidney: a case report and a literature review
por: Bakavičius, Arnas, et al.
Publicado: (2018)

Treatment of recurrent stress urinary incontinence in women: comparison of treatment results for different surgical techniques
por: Cerniauskiene, Ausra, et al.
Publicado: (2014)

LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
por: Vezelis, Alvydas, et al.
Publicado: (2021)

Complications after male adjustable suburethral sling implantation
por: Cerniauskiene, Ausra, et al.
Publicado: (2020)

Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
por: Bosas, Paulius, et al.
Publicado: (2021)

Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases
por: Sadzeviciene, Ieva, et al.
Publicado: (2022)

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

The Role of TSHR, PTEN and RASSF1A Promoters’ Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma
por: Klimaitė, Raimonda, et al.
Publicado: (2022)

Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line
por: Kubiliute, Raimonda, et al.
Publicado: (2021)

Urine Molecular Biomarkers for Detection and Follow-Up of Small Renal Masses
por: Žalimas, Algirdas, et al.
Publicado: (2022)

Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy
por: Gao, Yuan, et al.
Publicado: (2016)

Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer
por: Morrison, Belinda F, et al.
Publicado: (2019)

Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study
por: Hwang, Insang, et al.
Publicado: (2015)

The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
por: Murray, Nigel P, et al.
Publicado: (2017)

Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance
por: Jeon, Hwang Gyun, et al.
Publicado: (2017)

Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?
por: Bosas, Paulius, et al.
Publicado: (2020)

Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests
por: Kubiliute, Raimonda, et al.
Publicado: (2021)

SARS-CoV-2 RT-qPCR Ct values in saliva and nasopharyngeal swab samples for disease severity prediction
por: Snipaitiene, Kristina, et al.
Publicado: (2023)

Prostate cancer solitary metastasis to anal canal: case report and review of literature
por: Dulskas, Audrius, et al.
Publicado: (2019)

US "likely to upstage CERN accelerator"
por: Turney, J E
Publicado: (1984)

The dilemma of partial nephrectomy and surgical upstaging
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2022)

Complications and their treatment after midurethral tape implantation using retropubic and transobturator approaches for treatment of female stress urinary incontinence
por: Barisiene, Marija, et al.
Publicado: (2018)

Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
por: Ferro, Matteo, et al.
Publicado: (2016)

Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging
por: Jeong, Seung-hwan, et al.
Publicado: (2016)

Associations of periodontal status in periodontitis and rheumatoid arthritis patients
por: Rovas, Adomas, et al.
Publicado: (2021)

Old men with prostate cancer have higher risk of Gleason score upgrading and pathological upstaging after initial diagnosis: a systematic review and meta-analysis
por: Wang, Xiaochuan, et al.
Publicado: (2021)

No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance
por: Herkommer, Kathleen, et al.
Publicado: (2020)

Determination of Whether Apex or Non-Apex Prostate Cancer Is the Best Candidate for the Use of Prostate-Specific Antigen Density to Predict Pathological Grade Group Upgrading and Upstaging after Radical Prostatectomy
por: Huang, Cong, et al.
Publicado: (2023)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
por: Vėželis, Alvydas, et al.
Publicado: (2021)

Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies
por: MacLean, Carol M., et al.
Publicado: (2023)

Lung cancer upstaging due to the COVID-19 pandemic
por: Vella, Claire, et al.
Publicado: (2021)

Surveillance of cfDNA Hot Spot Mutations in NSCLC Patients during Disease Progression
por: Sestokaite, Agne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o2l08fi6qv8nrc6vlf50j0vsjd